Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
We're
#AlnylamProud to welcome our first Co-op class of the new decade! This outstanding group of 33 co-ops and legal externs represents@Northeastern,@UMassAmherst and@BU_Law. Learn more about career development at Alnylam here: http://bit.ly/2Li20kD pic.twitter.com/Pb3cjRBjyK
-
We’re thrilled to share that ONPATTRO (patisiran) was awarded “Best New Drug” honors at last evening’s
#ScripAwards in London. Not only was ONPATTRO our first commercial product but it was also the world’s first FDA and EMA-approved#RNAi therapeutic.pic.twitter.com/ktrPI4FikV
-
On Tuesday evening in Amsterdam, we co-hosted a wonderful program of speakers & discussions about promoting
#diversityandinclusion in the#lifesciences industry in the#Netherlands and beyond. Thank you to all who made this important event possible!#biotechpic.twitter.com/NE58hkh8LG
-
Our 2019 R&D Day (our 10th!) is in full swing in NYC. We’re providing commercial and investigational program and platform updates. You can join via webcast here: http://bit.ly/2Ov60Qr or access the replay following the event.
#RNAipic.twitter.com/JXxMzL9xkb
-
Yesterday’s
@US_FDA approval of GIVLAARI (givosiran) is a landmark event for Alnylam and the patient community and also represents significant progress for GalNAc-conjugate#RNAi technology uniquely pioneered by Alnylam. Learn more: http://bit.ly/2s5buu1 pic.twitter.com/SORJ0WBohw -
Caring for a child diagnosed with a rare disease can be difficult, and parents often adapt to play multiple roles as the years go by. Natalie and Jared speak about raising their children, diagnosed with primary
#hyperoxaluria type 1 (PH1).#NFCMonth#BeCareCuriouspic.twitter.com/vnKYByThZvCaregiver Perspectives: The Skinner Family, PH1 -
Our COO Yvonne Greenstreet, MBChB, MBA joined other leaders from
@Roche,@pfizer,@LonzaPB and@MIT's Center for Biomedical Innovation earlier today for an insightful panel "Resolving Pharma’s Pricing Conundrum: A New Prescription" at the@FinancialTimes#FTPharma Conference.pic.twitter.com/z3UvaWR6fh
-
One week until a great event on
#DiversityInHealth honoring the legacy of#biotech pioneer Henri A. Termeer taking place on Nov 19 in Amsterdam. See the list of distinguished speakers and program below. We invite you to attend and register: http://bit.ly/31pIPvz#LifeSciencesNLpic.twitter.com/P8lwrqo9qs
-
Challenge Accepted->CHALLENGE CONQUERED! On 11/1, our David Jones (holding flag on the right) summited Mt. Kilimanjaro, Africa's highest peak at 19,341' while raising money for the Int'l CML Foundation. Congrats David! You've made us quite
#alnylamproud!@CureClimb#leukemiapic.twitter.com/awvWZaoyx0
-
Original works of art like this one submitted by patients and caregivers as part of our "Art of Living with hATTR
#Amyloidosis" program were on display this past weekend at the ATTR-Wild Type and Hereditary (Familial) Amyloidosis Support Group Meeting in Chicago.@AmyloidosisSupppic.twitter.com/MQVZmC2TNJ
-
We were honored to be considered among an outstanding field of contenders at last night’s
@GalienFdn#PrixGalien awards! It was an amazing evening with our team celebrating new therapies with true patient impact! Congrats to our friends at@spark_tx!pic.twitter.com/9Xxm7FFqFI
-
Exciting additional speakers have been added. See updated program below!pic.twitter.com/Awfg1QGzu5
Prikaži ovu nit -
We're happy to confirm a great lineup of speakers for an event on
#DiversityInHealth honoring the legacy of#biotech pioneer Henri A. Termeer taking place on Nov 19 in Amsterdam. See program below. We invite you to attend and register here: http://bit.ly/31pIPvz#LifeSciencesNLpic.twitter.com/tXhiK8XG6Q
Prikaži ovu nit -
We’re very proud to share that we’ve won the 2019 Prix Galien Italy Orphan Drug Award. Congratulations to all of the other winners from today’s event, and all of this year’s nominees!
#PrixGalien@PrixGalien@shcitalypic.twitter.com/F1zrgwXjRM
-
Alnylam Assist – our U.S. patient services program, is central to our commitment to patients and ensuring they have access to the medicines we make. Case managers like Jessica are inspired by the patients and families they support, and our mission to always put
#patientsfirst.pic.twitter.com/gjhwymdVQPAlnylam Assist - What inspires Case Manager Jessica? -
The next PH1 of a Kind video has arrived! Watch as Luuk and older brother Sem from The Netherlands talk about life with the
#raredisease PH1 (primary#hyperoxaluria type 1), and Sem helps Luuk understand why he’s not alone and should feel hopeful. Co-developed w/@OHFtweetpic.twitter.com/bl7iCkJKOGPH1 of a Kind - Luuk’s Story: Learning to Have Hope -
At the culmination of this year’s
#PainAwarenessMonth, we wore blue to show our support for those living with debilitating conditions like acute hepatic#porphyria (AHP).#LetsTalkAboutPainpic.twitter.com/MiR6AnxaoC
-
Alnylam Assist provides patients in the U.S. prescribed our
#hATTR#amyloidosis therapy with a broad range of services from answering questions about insurance coverage to financial support for eligible patients.pic.twitter.com/kHRGCqzh2ULearn about how Alnylam Assist Case Managers help -
We’re thrilled to share that we’ve won the Prix Galien Netherlands Pharmaceutical Award 2019. Congratulations to all of the other winners from last evening’s event, and all of this year’s nominees!
#PrixGalien@PrixGalien@prix_galienpic.twitter.com/TFoERyoPa7
-
Our case managers like Caileen provide U.S. patients prescribed our medicines with personal and personalized support to help them navigate the process of starting therapy. Alnylam Assist is a critical part of our commitment to ensuring patient access.pic.twitter.com/XDSKVgq7r7
Alnylam Assist - What inspires Case Manager Caileen?
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.